Neutrophil gelatinase-associated lipocalin in dialyzed patients is related to residual renal function, type of renal replacement therapy and inflammation

Kidney and Blood Pressure Research

Volumn 32, Issue 6, 2010, Pages 464-469

  Malyszko, Jolanta ^a,b   Malyszko, Jacek S ^a,b   Koc Zorawska, Ewa ^a,b   Kozminski, Piotr ^a,b   Mysliwiec, Michal ^a,b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Dialysis Unit   (Poland)

Author keywords

Hemodiafiltration; Hemodialysis; Inflammation; NGAL; Residual renal function

Indexed keywords

C REACTIVE PROTEIN; CELLULOSE; CREATININE; FERRITIN; INTERLEUKIN 6; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; POLYSULFONE; TUMOR NECROSIS FACTOR ALPHA; UREA;

ADULT; ANURIA; ARTICLE; ARTIFICIAL KIDNEY; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE MARKER; HEMODIAFILTRATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; NEPHRITIS; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY;

ACUTE-PHASE PROTEINS; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INFLAMMATION; INTERLEUKIN-6; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; LIPOCALINS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 73649130295     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000274048     Document Type: Article

References (24)

1. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N: Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993; 268:10425-10432.
2. Cowland JB, Borregaard N: Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associ-ated lipocalin from humans. Genomics 1997; 45:17-23.
3. Friedl A, Stoesz SP, Buckley P, Gould MN: Neutrophil gelatinase- associated lipocalin in normal and neoplastic human tissues: cell type-specific pattern of expression. Histochem J 1999;31:433-441.
4. Yan L, Borregaard N, Kjeldsen L, Moses MA: The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 2001;276:37258-37265.
5. Monier F, Surla A, Guillot M, Morel F: Gelatinase isoforms in urine from bladder cancer patients. Clin Chim Acta 2000;299:11-23.
6. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet.2005;365:1231-1238.
7. Mitsnefes MM, Kathman TS, Mishra J, et al: Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol 2007;22:101-108.
8. Malyszko J, Bachorzewska-Gajewska H, Sitniewska E, Malyszko JS, Poniatowski B, Dobrzycki S: Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease. Ren Fail 2008;30:1-4.
9. Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, Fazio MR, Nicocia G, Buemi M: Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 2009;4:337-344.
10. Bolignano D, Lacquaniti A, Coppolino G, Donato V, Fazio MR, Nicocia G, Buemi M: Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press Res 2009; 32:91-98.
11. Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Pawlak K, Dobrzycki S: Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease. Nephrology (Carlton) 2008; 13: 153-156.
12. Modification of diet in Renal Disease Study Group: Creatinine filtration, secretion and excretion during progressive renal disease. Kidney Int 1989;36:S73-S80.
13. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612.
14. Malyszko J, Malyszko JS, Bachorzewska-Gajewska H, Poniatowski B, Dobrzycki S, Mysliwiec M: Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients. Transplant Proc 2009;41:158-161.
15. Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, Schmidt-Ott KM, Chen X, Li JY, Weiss S, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D'Agati V, Devarajan P, Barasch J: Endocytic delivery of lipocalin-sidero-phore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005;115:610-621.
16. Schmidt-Ott KM, Mori K, Kalandadze A, Li JY, Paragas N, Nicholas T, Devarajan P, Barasch J: Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia. Curr Opin Nephrol Hypertens 2006; 15:442-449.
17. Grigoryev DN, Liu M, Hassoun HT: The local and systemic inflammatory transcriptome after acute kidney injury. J Am Soc Nephrol 2008;19:547-558.
18. Schmitt-Ott KM, Mori K, Li JY, Kalandadze A, Cohen DJ, Devarajan P, Barasch J: Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2007; 18:407-413.
19. Okusa MD: The inflammatory cascade in acute ischemic renal failure. Nephron 2002; 90:133-138.
20. Hemdahl AL, Gabrielsen A, Zhu C, Eriksson P, Hedin U, Kastrup J, Thoren P, Hansson GK: Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler Thromb Vasc Biol 2006;26:136-142.
21. Malyszko J, Malyszko JS, Mysliwiec M: Comparison of hemostatic disturbances between patients on CAPD and patients on hemodialysis. Perit Dial Int 2001;21:158-165.
22. Tonelli M, Sacks F, Pfeffer M, Jhangri GS, Curhan G; Cholesterol and Recurrent Events (CARE) Trial Investigators. Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 2005;68:237-245.
23. Panichi V, Migliori M, De Pietro S, Taccola D, Bianchi AM, Norpoth M, Metelli MR, Giovannini L, Tetta C, Palla R: C-reactive protein in patients with chronic renal diseases. Ren Fail 2001;23:551-562.
24. Pecoits-Filho R, Heimburger O, Barany P, Suliman M: Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 2003;41:1212-1218.